Seattle, WA · Founded 2018 · Privately Held (backing)
Developer of a microscopy imaging system designed to analyze images of complex and morphological structures of tissue samples. Alpenglow Biosciences is based in Seattle, WA and was founded in 2018. Its last reported valuation was $14.6 million in Jun 2021. It has raised $9.8 million across 1 recorded round; the latest was a $3 million seed round in Mar 2024.
Last reported valuation
$14.6M
Oct 2026
Priced at
—
Total raised
$9.8M
Last round
Seed Round
Mar 2024
Cap table — not yet on record
Alpenglow Biosciences's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Alpenglow Biosciences with a free account
·The complete investor list: 12 names
·Watch Alpenglow Biosciences: the Monday email on marks, rounds and moves
Where does Alpenglow Biosciences's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Alpenglow Biosciences's 1 recorded funding rounds.
